SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-002809
Filing Date
2024-02-06
Accepted
2024-02-06 16:42:03
Documents
1
Period of Report
2024-02-02

Document Format Files

Seq Description Document Type Size
1 form4-02062024_090255.html 4  
1 form4-02062024_090255.xml 4 3436
  Complete submission text file 0001415889-24-002809.txt   4886
Mailing Address 350 FIFTH AVENUE, SUITE 7530 NEW YORK NY 10118
Business Address
Alam Kamran (Reporting) CIK: 0001793412 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39536 | Film No.: 24600858

Mailing Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247
Business Address 3000 PEGASUS PARK DRIVE SUITE 1430 DALLAS TX 75247 (214) 612-0000
Taysha Gene Therapies, Inc. (Issuer) CIK: 0001806310 (see all company filings)

IRS No.: 843199512 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)